Work

27475 Efficacy of the BIIB059 monoclonal antibody against BDCA2 in active cutaneous lupus erythematosus (CLE): Subgroup analyses of participants with or without systemic LE (SLE) and with different levels of disease activity

Year: 2021

Type: article

Source: Journal of the American Academy of Dermatology

DOI: 10.1016/j.jaad.2021.06.602

Authors: Victoria P. Werth, Richard A. Furie, Filippa Nyberg, Howard Sofen, Benjamin F. Chong, Xiaobi Huang, Hua Carroll, Adam Meyers, Catherine Barbey, Cristina Musselli, Nathalie Franchimont

Institutions: Philadelphia VA Medical Center, University of Pennsylvania, Northwell Health, Karolinska University Hospital, University of California, Los Angeles, The University of Texas Southwestern Medical Center, Biogen (United States), Biogen (Switzerland)

Language: English

Topic: Systemic Lupus Erythematosus Research

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3194730269

FWCI:

Cites:

Cited by:

Related to: 10